The Initial Relationship Between the United States Department of Health and Human Services' Digital COVID-19 Public Education Campaign and Vaccine Uptake: Campaign Effectiveness Evaluation.

COVID-19 COVID-19 pandemic COVID-19 vaccination United States campaign communication campaign digital impression marketing patient education public education public education campaign public health campaign social marketing vaccination vaccine

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
03 05 2023
Historique:
received: 28 10 2022
accepted: 06 03 2023
revised: 03 03 2023
medline: 5 5 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: epublish

Résumé

Over 1 million people in the United States have died of COVID-19. In response to this public health crisis, the US Department of Health and Human Services launched the We Can Do This public education campaign in April 2021 to increase vaccine confidence. The campaign uses a mix of digital, television, print, radio, and out-of-home channels to reach target audiences. However, the impact of this campaign on vaccine uptake has not yet been assessed. We aimed to address this gap by assessing the association between the We Can Do This COVID-19 public education campaign's digital impressions and the likelihood of first-dose COVID-19 vaccination among US adults. A nationally representative sample of 3642 adults recruited from a US probability panel was surveyed over 3 waves (wave 1: January to February 2021; wave 2: May to June 2021; and wave 3: September to November 2021) regarding COVID-19 vaccination, vaccine confidence, and sociodemographics. Survey data were merged with weekly paid digital campaign impressions delivered to each respondent's media market (designated market area [DMA]) during that period. The unit of analysis was the survey respondent-broadcast week, with respondents nested by DMA. Data were analyzed using a multilevel logit model with varying intercepts by DMA and time-fixed effects. The We Can Do This digital campaign was successful in encouraging first-dose COVID-19 vaccination. The findings were robust to multiple modeling specifications, with the independent effect of the change in the campaign's digital dose remaining practically unchanged across all models. Increases in DMA-level paid digital campaign impressions in a given week from -30,000 to 30,000 increased the likelihood of first-dose COVID-19 vaccination by 125%. Results from this study provide initial evidence of the We Can Do This campaign's digital impact on vaccine uptake. The size and length of the Department of Health and Human Services We Can Do This public education campaign make it uniquely situated to examine the impact of a digital campaign on COVID-19 vaccination, which may help inform future vaccine communication efforts and broader public education efforts. These findings suggest that campaign digital dose is positively associated with COVID-19 vaccination uptake among US adults; future research assessing campaign impact on reduced COVID-19-attributed morbidity and mortality and other benefits is recommended. This study indicates that digital channels have played an important role in the COVID-19 pandemic response. Digital outreach may be integral in addressing future pandemics and could even play a role in addressing nonpandemic public health crises.

Sections du résumé

BACKGROUND
Over 1 million people in the United States have died of COVID-19. In response to this public health crisis, the US Department of Health and Human Services launched the We Can Do This public education campaign in April 2021 to increase vaccine confidence. The campaign uses a mix of digital, television, print, radio, and out-of-home channels to reach target audiences. However, the impact of this campaign on vaccine uptake has not yet been assessed.
OBJECTIVE
We aimed to address this gap by assessing the association between the We Can Do This COVID-19 public education campaign's digital impressions and the likelihood of first-dose COVID-19 vaccination among US adults.
METHODS
A nationally representative sample of 3642 adults recruited from a US probability panel was surveyed over 3 waves (wave 1: January to February 2021; wave 2: May to June 2021; and wave 3: September to November 2021) regarding COVID-19 vaccination, vaccine confidence, and sociodemographics. Survey data were merged with weekly paid digital campaign impressions delivered to each respondent's media market (designated market area [DMA]) during that period. The unit of analysis was the survey respondent-broadcast week, with respondents nested by DMA. Data were analyzed using a multilevel logit model with varying intercepts by DMA and time-fixed effects.
RESULTS
The We Can Do This digital campaign was successful in encouraging first-dose COVID-19 vaccination. The findings were robust to multiple modeling specifications, with the independent effect of the change in the campaign's digital dose remaining practically unchanged across all models. Increases in DMA-level paid digital campaign impressions in a given week from -30,000 to 30,000 increased the likelihood of first-dose COVID-19 vaccination by 125%.
CONCLUSIONS
Results from this study provide initial evidence of the We Can Do This campaign's digital impact on vaccine uptake. The size and length of the Department of Health and Human Services We Can Do This public education campaign make it uniquely situated to examine the impact of a digital campaign on COVID-19 vaccination, which may help inform future vaccine communication efforts and broader public education efforts. These findings suggest that campaign digital dose is positively associated with COVID-19 vaccination uptake among US adults; future research assessing campaign impact on reduced COVID-19-attributed morbidity and mortality and other benefits is recommended. This study indicates that digital channels have played an important role in the COVID-19 pandemic response. Digital outreach may be integral in addressing future pandemics and could even play a role in addressing nonpandemic public health crises.

Identifiants

pubmed: 36939670
pii: v25i1e43873
doi: 10.2196/43873
pmc: PMC10158813
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e43873

Subventions

Organisme : NIH HHS
ID : 75N98019D00010
Pays : United States
Organisme : NIH HHS
ID : 75N98022C00001
Pays : United States

Informations de copyright

©Christopher J Williams, Elissa C Kranzler, Joseph N Luchman, Benjamin Denison, Sean Fischer, Thomas Wonder, Ronne Ostby, Monica Vines, Jessica Weinberg, Elizabeth L Petrun Sayers, Allison N Kurti, Sarah Trigger, Leah Hoffman, Joshua F A Peck. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 03.05.2023.

Références

Vaccines (Basel). 2021 Aug 13;9(8):
pubmed: 34452026
Am J Prev Med. 2009 May;36(5):379-84
pubmed: 19211213
Lancet. 2010 Oct 9;376(9748):1261-71
pubmed: 20933263
Lancet. 2013 Dec 14;382(9909):2003-11
pubmed: 24029166
Transl Behav Med. 2021 Sep 15;11(9):1782-1788
pubmed: 34293163
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Mayo Clin Proc. 2021 Mar;96(3):699-707
pubmed: 33673921
J Health Commun. 2016;21(4):439-56
pubmed: 26953782
Sci Rep. 2021 Nov 4;11(1):21844
pubmed: 34737319
Front Public Health. 2021 Nov 23;9:770985
pubmed: 34888288
J Health Commun. 2022 Mar 4;27(3):201-207
pubmed: 35467495
Vaccine. 2015 Aug 14;33(34):4180-90
pubmed: 25896377
MMWR Morb Mortal Wkly Rep. 2017 Jan 20;66(2):47-50
pubmed: 28103214
J Community Health. 2022 Jun;47(3):408-415
pubmed: 35079933
Hum Vaccin Immunother. 2022 Nov 30;18(5):2043102
pubmed: 35417302
BMC Infect Dis. 2021 Apr 12;21(1):338
pubmed: 33845781

Auteurs

Christopher J Williams (CJ)

Fors Marsh, Arlington, VA, United States.

Elissa C Kranzler (EC)

Fors Marsh, Arlington, VA, United States.

Joseph N Luchman (JN)

Fors Marsh, Arlington, VA, United States.

Benjamin Denison (B)

Fors Marsh, Arlington, VA, United States.

Sean Fischer (S)

Fors Marsh, Arlington, VA, United States.

Thomas Wonder (T)

Fors Marsh, Arlington, VA, United States.

Ronne Ostby (R)

Fors Marsh, Arlington, VA, United States.

Monica Vines (M)

US Department of Health and Human Services, Office of the Assistant Secretary for Public Affairs, Washington, DC, United States.

Jessica Weinberg (J)

US Department of Health and Human Services, Office of the Assistant Secretary for Public Affairs, Washington, DC, United States.

Elizabeth L Petrun Sayers (EL)

US Department of Health and Human Services, Office of the Assistant Secretary for Public Affairs, Washington, DC, United States.

Allison N Kurti (AN)

US Department of Health and Human Services, Office of the Assistant Secretary for Public Affairs, Washington, DC, United States.

Sarah Trigger (S)

US Department of Health and Human Services, Office of the Assistant Secretary for Public Affairs, Washington, DC, United States.

Leah Hoffman (L)

Fors Marsh, Arlington, VA, United States.

Joshua F A Peck (JFA)

US Department of Health and Human Services, Office of the Assistant Secretary for Public Affairs, Washington, DC, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH